Sulfamethoxazole

From Self-sufficiency
Jump to: navigation, search
Sulfamethoxazole
File:Sulfamethoxazole.png
File:Sulfamethoxazole.gif
Systematic (IUPAC) name
4-amino-N-(5-methylisoxazol-3-yl)-benzenesulfonamide
Clinical data
Pregnancy
category
Routes of
administration		 Oral
Legal status
Legal status
  • AU: S4 (Prescription only)
  • ℞ (Prescription only)
Pharmacokinetic data
Protein binding 70%
Metabolism Hepatic acetylation and glucuronidation
Biological half-life 10 hours
Excretion Renal
Identifiers
CAS Number 723-46-6
ATC code J01EC01 (WHO) QJ01EQ11
PubChem CID 5329
DrugBank APRD00076
ChemSpider 5138
Chemical data
Formula C10H11N3O3S
Molar mass 253.279 g/mol[[Script error: No such module "String".]]
Script error: No such module "collapsible list".
Physical data
Melting point 169 °C (336 °F)
  (verify)
Script error: No such module "TemplatePar".Expression error: Unexpected < operator.

Sulfamethoxazole (abbreviated SMX[1][2] and less reliably[3] SMZ[4][5][6]) is a sulfonamide bacteriostatic antibiotic. It is most often used as part of a synergistic combination with trimethoprim in a 5:1 ratio in co-trimoxazole (abbreviated SXT, SMX-TMP and SMZ-TMP,[7] or TMP-SMX and TMP-SMZ), also known under trade names such as Bactrim, Septrin, or Septra; in Eastern Europe it is marketed as Biseptol. Its primary activity is against susceptible forms of Streptococcus, Staphylococcus aureus (including MRSA), Escherichia coli, Haemophilus influenzae, and oral anaerobes. It is commonly used to treat urinary tract infections. In addition can be used as an alternative to amoxicillin-based antibiotics to treat sinusitis. It can also be used to treat toxoplasmosis.

Other names include: sulfamethylisoxazol, sulfisomezole, MS 53, RO 4 2130,[8][1][2] and sulfamethazole.[9]

Mechanism of action

Sulfonamides are structural analogs and competitive antagonists of para-aminobenzoic acid (PABA). They inhibit normal bacterial utilization of PABA for the synthesis of folic acid, an important metabolite in DNA synthesis.[10] The effects seen are usually bacteriostatic in nature. Folic acid is not synthesized in humans, but is instead a dietary requirement. This allows for the selective toxicity to bacterial cells (or any cell dependent on synthesizing folic acid) over human cells. Bacterial resistance to sulfamethoxazole are caused by mutations in the folic acid enzyme that inhibit PABA from binding and block folic acid synthesis.

File:THFsynthesispathway.png
Tetrahydrofolate synthesis pathway

Side effects

The most common side effect of sulfamethoxazole/trimethoprim is gastrointestinal upset. Allergies to sulfa-based medications typically cause skin rashes, hives, or trouble breathing or swallowing and warrant immediate discontinuation of the medication and contact with doctor immediately. Sulfamethoxazole/trimethoprim is also known to increase blood concentrations of the drug warfarin (U.S. brand name: Coumadin) and can cause an unexpected increase in clotting time and uncontrolled bleeding. Neutropenia and thrombocytopenia also are rare adverse effects to be monitored if a patient is placed on long-term therapy.

Gardnerella

A TM-SXT (or simply SXT) disk impregnated with trimethoprim and sulfamethoxazole may be used to help identify an organism as Gardnerella vaginalis; it is sensitive to the TM-SXT disk. Sulfamethoxazole can also cause nausea, severe stomach or abdomen pains. Headaches commonly occur when taking sulfamethoxazole. Muscle pains sometimes occur when taking this medicine. If symptoms persist or you have trouble breathing or you have swelling of the face, mouth or tongue discontinue medicine or get emergency medical help for swelling of the face, mouth or tongue. These are often symptoms of a severe allergic reaction.

See also

Notes

Cite error: Invalid <references> tag; parameter "group" is allowed only.

Use <references />, or <references group="..." />

References

External links

Antifolates
(inhibits
purine metabolism,
thereby inhibiting
DNA and RNA synthesis)
Sulfamethoxazole · Sulfadiazine# · Sulfamoxole
Other/ungrouped
Combinations
Topoisomerase
inhibitors/
quinolones/
(inhibits
DNA replication)
Related agents (DG)
Anaerobic DNA
inhibitors
Nitro- imidazole derivatives
Nitrofuran derivatives
RNA synthesis

M: BAC

drug(J1p, w, n, m, vacc)

de:Sulfamethoxazol

es:Sulfametoxazol ja:スルファメトキサゾール sk:Sulfametoxazol th:ซัลฟาเมโทซาโซล

zh:磺胺甲噁唑
  1. ↑ 1.0 1.1 PubChem, "Sulfamethoxazole - Substance Summary"
  2. ↑ 2.0 2.1 ChemDB, "Sulfamethoxazole"
  3. ↑ "SMZ" is not found in databases, but often seen in the published literature; it could however be confused with sulfamethazine, also seen abbreviated SMZ.
  4. ↑ Ma, M.; Cheng, Y.; Xu, Z.; Xu, P.; Qu, H.; Fang, Y.; Xu, T.; Wen, L. (2007). "Evaluation of polyamidoamine (PAMAM) dendrimers as drug carriers of anti-bacterial drugs using sulfamethoxazole (SMZ) as a model drug". European journal of medicinal chemistry. 42 (1): 93–8. doi:10.1016/j.ejmech.2006.07.015. PMID 17095123. 
  5. ↑ Garg, S.K.; Ghosh, S.S.; Mathur, V.S. (1986). "Comparative pharmacokinetic study of four different sulfonamides in combination with trimethoprim in human volunteers". International journal of clinical pharmacology, therapy, and toxicology. 24 (1): 23–5. PMID 3485584. 
  6. ↑ SMZ in Abstract of "Rat model of concurrent Pneumocystis carinii (Pc), Toxoplasma gondii (Tg), and Mycobacterium avium complex (MAC) infections for assessment of multiple prophylaxis" at ncbi.nlm.nih.gov
  7. ↑ SMZ-TMP in Abstract of "Cutaneous hypersensitivity to sulfamethoxazole-trimethoprim (SMZ TMP) in HIV infected patients" at nlm.nih.gov
  8. ↑ BIAM, "Sulfamethoxazole"
  9. ↑ Sulfamethazole in "Clinical Diabetes: Case Study: A 90-Year-Old Man With Confusion and Night Sweats", and "Chronic Granulomatous Disease"
  10. ↑ Martindale, The extra pharmacopoeia, 30th ed, p. 208
Retrieved from "http://ssf.f15ijp.com/wiki/index.php?title=Sulfamethoxazole&oldid=32772"